Literature DB >> 12478066

Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors.

Ronit Ben-Romano1, Assaf Rudich, Dóra Török, Sharon Vanounou, Klaris Riesenberg, Francisc Schlaeffer, Amira Klip, Nava Bashan.   

Abstract

OBJECTIVE: To test agent and cell-type specificity in insulin resistance induced by prolonged exposure to HIV protease inhibitors (HPI), and to assess its relation to the direct, short-term inhibition of insulin-stimulated glucose uptake.
METHODS: Following prolonged (18 h) and short (5-10 min) exposure to HPI, insulin-stimulated glucose transport, protein kinase B (PKB) phosphorylation, and GLUT4 translocation were evaluated in 3T3-L1 adipocytes, fibroblasts, L6 myotubes, and L6 cells overexpressing a myc tag on the first exofacial loop of GLUT4 or GLUT1.
RESULTS: Prolonged exposure of 3T3-L1 adipocytes to nelfinavir, but not to indinavir or saquinavir, resulted in increased basal lipolysis but decreased insulin-stimulated glucose transport and PKB phosphorylation. In addition, impaired insulin-stimulated glucose uptake and PKB phosphorylation were also observed in the skeletal muscle cell line L6, and in 3T3-L1 fibroblasts. Interestingly, this coincided with increased basal glucose uptake as well as with elevated total-membrane glucose transporter GLUT1 protein content. In contrast to these unique effects of nelfinavir, the mere presence of any of the agents in the 5 min transport assay inhibited insulin-stimulated glucose-uptake activity. This appeared to be caused by direct and specific interaction of the drugs with GLUT4 fully assembled at the plasma membrane, since insulin-stimulated cell-surface exposure of an exofacial myc epitope on GLUT4 was normal.
CONCLUSIONS: Independent mechanisms for HPI-induced insulin resistance exist: prolonged exposure to nelfinavir interferes with insulin signaling and alters cellular metabolism of adipocytes and muscle cells, whereas a direct inhibitory effect on insulin-stimulated glucose uptake may occurs through specific interaction of HPI with GLUT4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12478066     DOI: 10.1097/00002030-200301030-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  20 in total

1.  New HIV Drugs in Development, 2005.

Authors:  Jeffrey P Nadler; Michael C Phillips
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

2.  Repositioning HIV protease inhibitors as cancer therapeutics.

Authors:  Wendy B Bernstein; Phillip A Dennis
Journal:  Curr Opin HIV AIDS       Date:  2008-11       Impact factor: 4.283

Review 3.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

Review 4.  Molecular mechanisms for insulin resistance in treated HIV-infection.

Authors:  Paul W Hruz
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-06       Impact factor: 4.690

5.  Postreceptoral adipocyte insulin resistance induced by nelfinavir is caused by insensitivity of PKB/Akt to phosphatidylinositol-3,4,5-trisphosphate.

Authors:  Ilana Kachko; Adva Maissel; Livnat Mazor; Ronit Ben-Romano; Robert T Watson; June C Hou; Jeffrey E Pessin; Nava Bashan; Assaf Rudich
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

6.  Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis.

Authors:  Diane C Adler-Wailes; Hanguan Liu; Faiyaz Ahmad; Ningping Feng; Constantine Londos; Vincent Manganiello; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

7.  Association of Metabolic Syndrome and Oxidative DNA Damage in HIV/AIDS Patients.

Authors:  Vaishali Kolgiri; Vidya Nagar; Vinayak Patil
Journal:  Indian J Clin Biochem       Date:  2017-06-12

8.  Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.

Authors:  Stephen Arpadi; Stephanie Shiau; Renate Strehlau; Leigh Martens; Faeezah Patel; Ashraf Coovadia; Elaine J Abrams; Louise Kuhn
Journal:  Arch Dis Child       Date:  2012-12-05       Impact factor: 3.791

Review 9.  Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.

Authors:  Emma Kaplan-Lewis; Judith A Aberg; Mikyung Lee
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

10.  Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems.

Authors:  Debbie M Cheng; Howard Libman; Carly Bridden; Richard Saitz; Jeffrey H Samet
Journal:  Alcohol       Date:  2009-02       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.